Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Reference10 articles.
1. Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects;Dalvin;Retina,2018
2. Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review;Fisher;J Am Acad Dermatol.,2019
3. Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report;Kwatra;J Med Case Rep.,2017
4. Tumor regression and allograft rejection after administration of anti-PD-1;Lipson;N Engl J Med.,2016
5. Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience;DeLeon;J Gastrointest Oncol.,2018
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Corneal Transplant Rejection Following Durvalumab Therapy in a Patient With NSCLC: A Case Report;Journal of Immunotherapy;2024-07-30
2. Adverse effects of anti-cancer biologics on the ocular surface;Current Opinion in Allergy & Clinical Immunology;2024-07-04
3. Ocular Surface Side Effects of Novel Anticancer Drugs;Cancers;2024-01-13
4. Ocular surface complications following biological therapy for cancer;Frontiers in Toxicology;2023-06-22
5. A Case of Bilateral Keratitis and Bilateral Anterior Uveitis Induced by Pembrolizumab;Cornea Open;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3